Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jiang-tao Hou"'
Autor:
Jianfeng Luo, Jiamin Zhong, Haiwen Li, Shijing Zhang, Liwan Zhang, Jiang-tao Hou, Junyu Ke, Huibiao Li, Fengbin Liu, Xin-lin Chen
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Inflammatory bowel disease (IBD) has become a global public health problem. The prevalence of IBD in China increased annually in past two decades. Methods This study was to translate and validate the rating form of IBD patients' c
Externí odkaz:
https://doaj.org/article/6d9ccd75b4ff4fa2a685e0f6d1042a8b
Autor:
Jiang-tao Hou, Bin Peng, Shi-jing Zhang, Yong-xin Luo, Yi-ming Chen, Jia-zhong Cai, Yi Wen, Hong Mi, Jian-feng Luo, Xiao-mei Zheng, Si-min Pan, Shi-ying Liu, Xin-lin Chen, Bin Chen
Publikováno v:
Palliative Medicine Reports, Vol 3, Iss 1, Pp 154-161 (2022)
Background: The aim of our study was to translate and validate the mainland Chinese version of the short health scale (SHS), a disease-specific quality-of-life (QoL) scale for patients with inflammatory bowel disease (IBD). Methods: The SHS was trans
Externí odkaz:
https://doaj.org/article/e11cced022a948fe9fde450abee11707
Autor:
Yi-ming Chen, Jie-min Deng, Yi Wen, Bin Chen, Jiang-tao Hou, Bin Peng, Shi-jing Zhang, Hong Mi, Qi-long Jiang, Xia-lin Wu, Feng-bin Liu, Xin-lin Chen
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background Modified Sijunzi decoction (SJZD) has been used to treat ulcerative colitis (UC) in remission. However, more rigorous clinical trials are necessary to evaluate its effectiveness. Therefore, a series of single-case randomised contr
Externí odkaz:
https://doaj.org/article/6afef308c9ef4d989fecbac44c31450f
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Inflammatory bowel disease (IBD), denominated by Crohn’s disease and ulcerative colitis, is often associated with abdominal pain, diarrhea and bloody stool. The standard protocols for treating colitis conditions are not satisfac
Externí odkaz:
https://doaj.org/article/bc8f4e47a1f84e57a26d38d182297947
Autor:
Shi-Jing Zhang, Jian-Feng Luo, Bin Peng, Jiang-Tao Hou, Qian Xu, Li-Xia Chen, Hui-Biao Li, Shi-Ying Liu, Jia-Min Zhong, Zhen-Fang He, Xin-Lin Chen
Publikováno v:
World Chinese Journal of Digestology. 30:17-23
Autor:
Si-min Pan, Jian-feng Luo, Bin Peng, Yi Wen, Shijing Zhang, Yi-Ming Chen, Xiao-mei Zheng, Jiang-tao Hou, Yong-xin Luo, Jia-zhong Cai, Hong Mi, Bin Chen, Shi-ying Liu, Xinlin Chen
Background: The aim of our study was to translate and validate the Chinese version of the Short Health Scale (SHS), a disease-specific quality of life (QoL) scale for the patients with inflammatory bowel disease (IBD).Methods: The SHS was translated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::063539c3c6d8d2ef9f24e0128c2522b9
https://doi.org/10.21203/rs.3.rs-380504/v1
https://doi.org/10.21203/rs.3.rs-380504/v1
Autor:
Fengbin Liu, Xia-Lin Wu, Qi-Long Jiang, Jie-Min Deng, Bin Chen, Bin Peng, Xinlin Chen, Hong Mi, Shijing Zhang, Yi Wen, Yi-Ming Chen, Jiang-tao Hou
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Trials
Trials
Background Modified Sijunzi decoction (SJZD) has been used to treat ulcerative colitis (UC) in remission. However, more rigorous clinical trials are necessary to evaluate its effectiveness. Therefore, a series of single-case randomised controlled tri
Publikováno v:
Key Engineering Materials. 759:86-91
A wet powder metallurgy (WPM) process was developed to disperse carbon nanotubes (CNTs), and to fabricate the CNTs reinforced Mg matrix (CNTs/Mg) composite. The dispersion effect of CNTs were evaluated by field emission scanning electron microscopy (
Autor:
Weiling He, Li-zhen Chen, Ding-jun Zhang, Bin Chen, Jiang-tao Hou, Li-na Zhao, Dong-yong Lv, Pei-ru Li, Hui-biao Li, Xinlin Chen
Publikováno v:
Technology in Cancer Research & Treatment
DNA mismatch repair was proposed to play a pivotal role in the development and prognosis of colorectal cancer. However, the prognostic value of mismatch repair on colorectal cancer is still unknown. The PubMed, EMBASE, and Cochrane Central Register o
Autor:
Fengbin Liu, Qian Xu, Chuan-wei Mo, Weiling He, Xinlin Chen, Yujie Yuan, Chaoyuan Huang, Jiang-tao Hou, Zheng-kun Hou, Haiwen Li, Tian-wen Liu, Bin Chen
Publikováno v:
BioDrugs. 30:207-217
Evidence-based studies are increasingly being focused on evaluating the efficacy and safety of adalimumab (ADA) for moderately to severely active ulcerative colitis (UC). However, the dosage pattern of ADA for UC management is still not clear. A meta